Skip to main content
. 2018 Aug 31;20(10):86. doi: 10.1007/s11936-018-0679-y

Fig. 1.

Fig. 1

CMR using T1 mapping and ECV has a potential role in the exclusion of HCM in athletes presenting with LV hypertrophy.